Auxly Cannabis Financials
| XLY Stock | CAD 0.08 0.01 5.88% |
Auxly |
Understanding current and past Auxly Cannabis Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Auxly Cannabis' financial statements are interrelated, with each one affecting the others. For example, an increase in Auxly Cannabis' assets may result in an increase in income on the income statement.
Auxly Cannabis Stock Summary
Auxly Cannabis competes with OrganiGram Holdings, Tilray, and Medipharm Labs. Auxly Cannabis Group Inc. operates as a consumer-packaged goods company in the cannabis products market in Canada. Auxly Cannabis Group Inc. was incorporated in 1987 and is based in Toronto, Canada. AUXLY CANNABIS operates under Drug ManufacturersSpecialty Generic classification in Canada and is traded on Toronto Stock Exchange. It employs 558 people.| Foreign Associate | USA |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | Canada Stock View All |
| Exchange | Toronto Exchange |
| ISIN | CA05335P1099 |
| Business Address | 777 Richmond Street |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.auxly.com |
| Phone | (647) 812 0121 |
| Currency | CAD - Canadian Dollar |
You should never invest in Auxly Cannabis without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Auxly Stock, because this is throwing your money away. Analyzing the key information contained in Auxly Cannabis' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Auxly Cannabis Key Financial Ratios
Auxly Cannabis' financial ratios allow both analysts and investors to convert raw data from Auxly Cannabis' financial statements into concise, actionable information that can be used to evaluate the performance of Auxly Cannabis over time and compare it to other companies across industries.| Return On Equity | -0.71 | ||||
| Return On Asset | -3.0E-4 | ||||
| Target Price | 0.02 | ||||
| Number Of Employees | 369 | ||||
| Beta | 0.93 |
Auxly Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Auxly Cannabis's current stock value. Our valuation model uses many indicators to compare Auxly Cannabis value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Auxly Cannabis competition to find correlations between indicators driving Auxly Cannabis's intrinsic value. More Info.Auxly Cannabis Group is rated fourth in return on equity category among its peers. It is rated first in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Auxly Cannabis by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Auxly Cannabis' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Auxly Cannabis Group Systematic Risk
Auxly Cannabis' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Auxly Cannabis volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fifty with a total number of output elements of eleven. The Beta measures systematic risk based on how returns on Auxly Cannabis Group correlated with the market. If Beta is less than 0 Auxly Cannabis generally moves in the opposite direction as compared to the market. If Auxly Cannabis Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Auxly Cannabis Group is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Auxly Cannabis is generally in the same direction as the market. If Beta > 1 Auxly Cannabis moves generally in the same direction as, but more than the movement of the benchmark.
Auxly Cannabis March 22, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Auxly Cannabis help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Auxly Cannabis Group. We use our internally-developed statistical techniques to arrive at the intrinsic value of Auxly Cannabis Group based on widely used predictive technical indicators. In general, we focus on analyzing Auxly Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Auxly Cannabis's daily price indicators and compare them against related drivers.
| Downside Deviation | 11.94 | |||
| Information Ratio | 0.2252 | |||
| Maximum Drawdown | 43.18 | |||
| Value At Risk | (15.38) | |||
| Potential Upside | 16.67 |
Other Information on Investing in Auxly Stock
Auxly Cannabis financial ratios help investors to determine whether Auxly Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Auxly with respect to the benefits of owning Auxly Cannabis security.